![Clinical Studies in the Second Line Setting of Advanced Pancreatic Cancer: Are We Making Any Progress? | Insight Medical Publishing Clinical Studies in the Second Line Setting of Advanced Pancreatic Cancer: Are We Making Any Progress? | Insight Medical Publishing](https://pancreas.imedpub.com/articles-images/pancreas-13-4-6-t001.png)
Clinical Studies in the Second Line Setting of Advanced Pancreatic Cancer: Are We Making Any Progress? | Insight Medical Publishing
![CISCRP's 2019 Perceptions and Insights Study - Center for Information & Study on Clinical Research Participation CISCRP's 2019 Perceptions and Insights Study - Center for Information & Study on Clinical Research Participation](https://www.ciscrp.org/wp-content/uploads/2019/09/P-I-Chart-1024x576.png)
CISCRP's 2019 Perceptions and Insights Study - Center for Information & Study on Clinical Research Participation
![Demographic Disparities in Patient Samples for Drugs and Biologics Approved by FDA Between 2007-2017 Demographic Disparities in Patient Samples for Drugs and Biologics Approved by FDA Between 2007-2017](https://cdn.sanity.io/images/0vv8moc6/act/01e079a78c0ef0b448041af3635a2986b80d0425-629x178.png?fit=crop&auto=format)
Demographic Disparities in Patient Samples for Drugs and Biologics Approved by FDA Between 2007-2017
![Generalizability of findings from randomized controlled trials is limited in the leading general medical journals - Journal of Clinical Epidemiology Generalizability of findings from randomized controlled trials is limited in the leading general medical journals - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/17aadd0c-387d-46b9-aa67-228053392d77/gr1.jpg)
Generalizability of findings from randomized controlled trials is limited in the leading general medical journals - Journal of Clinical Epidemiology
![PDF) Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016 PDF) Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016](https://i1.rgstatic.net/publication/346643421_Clinical_Trial_Evidence_Supporting_US_Food_and_Drug_Administration_Approval_of_Novel_Cancer_Therapies_Between_2000_and_2016/links/5fcfee3045851568d14d6823/largepreview.png)
PDF) Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016
![Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8e9a80c5-3e9a-4f55-9f5e-4d0638d176a9/gr1_lrg.jpg)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic: Trends in Pharmacological Sciences
![A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study - ScienceDirect A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468024920314339-fx1.jpg)